Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
-240K
-
Total reported value, excl. options
-
$398M
-
Value change
-
+$12.8M
-
Number of buys
-
25
-
Number of sells
-
-16
-
Price
-
$24.52
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q4 2019
48 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2019.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 50.5M outstanding shares and own 32.19% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), FRAZIER MANAGEMENT LLC (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.45M shares), Novo Holdings A/S (2.45M shares), Rock Springs Capital Management LP (1.25M shares), BAKER BROS. ADVISORS LP (333K shares), BOXER CAPITAL, LLC (317K shares), BlackRock Inc. (181K shares), VANGUARD GROUP INC (80.4K shares), and ORBIMED ADVISORS LLC (71.3K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.